ciprofloxacin has been researched along with Arthritis in 14 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Arthritis: Acute or chronic inflammation of JOINTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral ciprofloxacin was used at doses ranging from 500 mg to 1500 mg twice daily for 15 to 476 (mean 139) days for treatment of acute or chronic osteomyelitis in 38 patients, and acute arthritis in two." | 9.06 | Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group. ( , 1988) |
| "Ciprofloxacin did not inhibit collagen induced arthritis in adrenalectomized rats but rather caused an exacerbation of the disease." | 5.28 | Protective effects of ciprofloxacin against type II collagen induced arthritis in rats. ( Breban, M; Fournier, C; Gougerot-Pocidalo, MA; Muffat-Joly, M; Pocidalo, JJ, 1992) |
| "Serum sickness is a systemic hypersensitivity reaction initially reported in children receiving horse serum." | 5.28 | Serum sickness-like illness associated with ciprofloxacin. ( Slama, TG, 1990) |
| "Oral ciprofloxacin was used at doses ranging from 500 mg to 1500 mg twice daily for 15 to 476 (mean 139) days for treatment of acute or chronic osteomyelitis in 38 patients, and acute arthritis in two." | 5.06 | Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group. ( , 1988) |
| "This brief review will clarify the association of quinolones with arthropathy, particularly ciprofloxacin because of its widespread use, and subsequently discuss the problem of defining that association in a population of children with cystic fibrosis." | 4.79 | Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones. ( Warren, RW, 1997) |
| " This work is based on the development and characterization of lipid nanoparticles of solid phase incorporating two antibiotics, minocycline, and ciprofloxacin with antinociceptive properties and challenged them with a rat monoarthritis model using Sprague-Dawley adult male rats." | 3.88 | Antinociceptive antibiotics-loaded into solid lipid nanoparticles of prolonged release: Measuring pharmacological efficiency and time span on chronic monoarthritis rats. ( Bustos, G; Laurido, C; Martinez, JL; Valdes, C, 2018) |
| "Thyroiditis was diagnosed with clinical inspection and confirmed by ultrasound investigation." | 1.51 | Acute Thyroiditis Associated with Brucellosis: A Case Report. ( Bitoska, I; Bosilkovski, M; Cvetkova, M; Jakimovski, D; Poposki, K, 2019) |
| "Ciprofloxacin treatment exhibited an independent protective effect (adjusted hazard ratio (aHR) 0." | 1.40 | Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. ( Ariza, J; Bahamonde, A; Baraia-Etxaburu, JM; Benito, N; Cobo, J; Corona, PS; del Toro, MD; Euba, G; Fernández-Sampedro, M; Flores-Sánchez, X; Guio, L; Iribarren, JA; Lora-Tamayo, J; Palomino, J; Pigrau, C; Ramos, A; Riera, M; Rodríguez-Pardo, D; Sánchez-Somolinos, M; Soriano, A; Sorli, L, 2014) |
| "The diagnosis of typhoid fever was made when blood cultures grew Salmonella typhi." | 1.33 | Multiorgan involvement due to Salmonella typhi: case report. ( Ollé-Goig, JE, 2006) |
| "Ciprofloxacin did not inhibit collagen induced arthritis in adrenalectomized rats but rather caused an exacerbation of the disease." | 1.28 | Protective effects of ciprofloxacin against type II collagen induced arthritis in rats. ( Breban, M; Fournier, C; Gougerot-Pocidalo, MA; Muffat-Joly, M; Pocidalo, JJ, 1992) |
| "Serum sickness is a systemic hypersensitivity reaction initially reported in children receiving horse serum." | 1.28 | Serum sickness-like illness associated with ciprofloxacin. ( Slama, TG, 1990) |
| "Ciprofloxacin is an effective and safe therapeutic alternative in many tissue infections caused by susceptible microorganisms." | 1.27 | Open, prospective study of the clinical efficacy of ciprofloxacin. ( Bran, JL; Garcia, JF; Mejia, CR; Ramirez, CA, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cvetkova, M | 1 |
| Bitoska, I | 1 |
| Poposki, K | 1 |
| Jakimovski, D | 1 |
| Bosilkovski, M | 1 |
| Valdes, C | 1 |
| Bustos, G | 1 |
| Martinez, JL | 1 |
| Laurido, C | 1 |
| Rodríguez-Pardo, D | 1 |
| Pigrau, C | 1 |
| Lora-Tamayo, J | 1 |
| Soriano, A | 1 |
| del Toro, MD | 1 |
| Cobo, J | 1 |
| Palomino, J | 1 |
| Euba, G | 1 |
| Riera, M | 1 |
| Sánchez-Somolinos, M | 1 |
| Benito, N | 1 |
| Fernández-Sampedro, M | 1 |
| Sorli, L | 1 |
| Guio, L | 1 |
| Iribarren, JA | 1 |
| Baraia-Etxaburu, JM | 1 |
| Ramos, A | 1 |
| Bahamonde, A | 1 |
| Flores-Sánchez, X | 1 |
| Corona, PS | 1 |
| Ariza, J | 1 |
| Micallef, C | 1 |
| Azzopardi, CM | 1 |
| Ollé-Goig, JE | 1 |
| Taylor-Robinson, D | 1 |
| Gilroy, CB | 1 |
| Horowitz, S | 1 |
| Horowitz, J | 1 |
| Warren, RW | 1 |
| Lindahl, G | 1 |
| Perman, E | 1 |
| Singh, UK | 1 |
| Sinha, RK | 1 |
| Prasad, B | 1 |
| Chakrabarti, B | 1 |
| Sharma, SK | 1 |
| Postnikov, SS | 1 |
| Breban, M | 1 |
| Fournier, C | 1 |
| Gougerot-Pocidalo, MA | 1 |
| Muffat-Joly, M | 1 |
| Pocidalo, JJ | 1 |
| Slama, TG | 1 |
| Ramirez, CA | 1 |
| Bran, JL | 1 |
| Mejia, CR | 1 |
| Garcia, JF | 1 |
1 review available for ciprofloxacin and Arthritis
| Article | Year |
|---|---|
Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Arthralgia; Arthritis; Child; Ciprofloxacin; Cystic Fibrosis; Humans | 1997 |
1 trial available for ciprofloxacin and Arthritis
| Article | Year |
|---|---|
Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group.
Topics: Acute Disease; Administration, Oral; Arthritis; Bacterial Infections; Chronic Disease; Ciprofloxacin | 1988 |
12 other studies available for ciprofloxacin and Arthritis
| Article | Year |
|---|---|
Acute Thyroiditis Associated with Brucellosis: A Case Report.
Topics: Acute Disease; Anti-Bacterial Agents; Arthritis; Brucellosis; Ciprofloxacin; Gentamicins; Humans; Ma | 2019 |
Antinociceptive antibiotics-loaded into solid lipid nanoparticles of prolonged release: Measuring pharmacological efficiency and time span on chronic monoarthritis rats.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Arthritis; Chronic Disease; Ciprofloxacin; Delayed-Actio | 2018 |
Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthritis; Ciprofloxacin; Debridement; Female; Gram- | 2014 |
Atypical cutaneous leishmaniasis in the immunosuppressed.
Topics: Adalimumab; Amoxicillin; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antimony Sodium G | 2014 |
Multiorgan involvement due to Salmonella typhi: case report.
Topics: Arthritis; Ceftriaxone; Child; Ciprofloxacin; Humans; Male; Osteomyelitis; Salmonella typhi; Typhoid | 2006 |
Mycoplasma genitalium in the joints of two patients with arthritis.
Topics: Adult; Arthritis; Arthritis, Reactive; Arthritis, Rheumatoid; Ciprofloxacin; Humans; Knee Joint; Lup | 1994 |
[Influenza vaccine caused problems in joints. Compensation from the drug insurance authority].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; | 1999 |
Ciprofloxacin in children: is arthropathy a limitation?
Topics: Adolescent; Anti-Infective Agents; Arthritis; Child; Child, Preschool; Ciprofloxacin; Humans; Infant | 2000 |
[Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].
Topics: Adolescent; Anti-Infective Agents; Arthritis; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosi | 2001 |
Protective effects of ciprofloxacin against type II collagen induced arthritis in rats.
Topics: Adrenal Cortex Hormones; Adrenalectomy; Animals; Arthritis; Body Weight; Ciprofloxacin; Collagen; Do | 1992 |
Serum sickness-like illness associated with ciprofloxacin.
Topics: Arthritis; Bacterial Infections; Ciprofloxacin; Drug Hypersensitivity; Humans; Liver Function Tests; | 1990 |
Open, prospective study of the clinical efficacy of ciprofloxacin.
Topics: Adolescent; Adult; Aged; Arthritis; Bacterial Infections; Ciprofloxacin; Female; Gastrointestinal Di | 1985 |